Integrating Tenascin-C protein expression and 1q25 copy number status in pediatric intracranial ependymoma prognostication: A new model for risk stratification.

Andreiuolo, F; Le Teuff, G; Bayar, M; Kilday, John-Paul; Pietsch, T; von Bueren, A; Witt, H; Korshunov, A; Modena, P; Pfister, S; Pagès, M; Castel, D; Giangaspero, F; Chimelli, L; Varlet, P; Rutkowski, S; Frappaz, D; Massimino, M; Grundy, R; Grill, J

dc.contributor.author	Andreiuolo, F
dc.contributor.author	Le Teuff, G
dc.contributor.author	Bayar, M
dc.contributor.author	Kilday, John-Paul
dc.contributor.author	Pietsch, T
dc.contributor.author	von Bueren, A
dc.contributor.author	Witt, H
dc.contributor.author	Korshunov, A
dc.contributor.author	Modena, P
dc.contributor.author	Pfister, S
dc.contributor.author	Pagès, M
dc.contributor.author	Castel, D
dc.contributor.author	Giangaspero, F
dc.contributor.author	Chimelli, L
dc.contributor.author	Varlet, P
dc.contributor.author	Rutkowski, S
dc.contributor.author	Frappaz, D
dc.contributor.author	Massimino, M
dc.contributor.author	Grundy, R
dc.contributor.author	Grill, J
dc.date.accessioned	2017-08-17T15:32:57Z
dc.date.available	2017-08-17T15:32:57Z
dc.date.issued	2017
dc.identifier.citation	Integrating Tenascin-C protein expression and 1q25 copy number status in pediatric intracranial ependymoma prognostication: A new model for risk stratification. 2017, 12 (6) PLoS ONE	en
dc.identifier.issn	1932-6203
dc.identifier.pmid	28617804
dc.identifier.doi	10.1371/journal.pone.0178351
dc.identifier.uri	http://hdl.handle.net/10541/620508
dc.description.abstract	Despite multimodal therapy, prognosis of pediatric intracranial ependymomas remains poor with a 5-year survival rate below 70% and frequent late deaths.
dc.language.iso	en	en
dc.rights	Archived with thanks to PloS one	en
dc.title	Integrating Tenascin-C protein expression and 1q25 copy number status in pediatric intracranial ependymoma prognostication: A new model for risk stratification.	en
dc.type	Article	en
dc.contributor.department	Université Paris-Sud, Gustave Roussy, CNRS UMR 8203 "Vectorologie et Thérapeutiques Anticancéreuses", Villejuif, France	en
dc.identifier.journal	PLoS ONE	en
refterms.dateFOA	2018-12-17T15:02:42Z
html.description.abstract	Despite multimodal therapy, prognosis of pediatric intracranial ependymomas remains poor with a 5-year survival rate below 70% and frequent late deaths.